Although some studies suggest that CBC might modulate inflammation and neurological functions through ECS receptors, such as TRPV1 and CB2, a significant gap in the understanding of its direct anti-cancer mechanisms remains [27]. This evidence concerns the gene TRPV1 and cancer.